Tag: Georgia Tech

Frontiers of Neuroscience: Neurohacking and Neuromorphics

neural-network-consciousness-downloading-640x353It is one of the hallmarks of our rapidly accelerating times: looking at the state of technology, how it is increasingly being merged with our biology, and contemplating the ultimate leap of merging mind and machinery. The concept has been popular for many decades now, and with experimental procedures showing promise, neuroscience being used to inspire the next great leap in computing, and the advance of biomedicine and bionics, it seems like just a matter of time before people can “hack” their neurology too.

Take Kevin Tracey, a researcher working for the Feinstein Institute for Medical Research in Manhasset, N.Y., as an example. Back in 1998, he began conducting experiments to show that an interface existed between the immune and nervous system. Building on ten years worth of research, he was able to show how inflammation – which is associated with rheumatoid arthritis and Crohn’s disease – can be fought by administering electrical stimulu, in the right doses, to the vagus nerve cluster.

Brain-ScanIn so doing, he demonstrated that the nervous system was like a computer terminal through which you could deliver commands to stop a problem, like acute inflammation, before it starts, or repair a body after it gets sick.  His work also seemed to indicate that electricity delivered to the vagus nerve in just the right intensity and at precise intervals could reproduce a drug’s therapeutic reaction, but with greater effectiveness, minimal health risks, and at a fraction of the cost of “biologic” pharmaceuticals.

Paul Frenette, a stem-cell researcher at the Albert Einstein College of Medicine in the Bronx, is another example. After discovering the link between the nervous system and prostate tumors, he and his colleagues created SetPoint –  a startup dedicated to finding ways to manipulate neural input to delay the growth of tumors. These and other efforts are part of the growing field of bioelectronics, where researchers are creating implants that can communicate directly with the nervous system in order to try to fight everything from cancer to the common cold.

human-hippocampus-640x353Impressive as this may seem, bioelectronics are just part of the growing discussion about neurohacking. In addition to the leaps and bounds being made in the field of brain-to-computer interfacing (and brain-to-brain interfacing), that would allow people to control machinery and share thoughts across vast distances, there is also a field of neurosurgery that is seeking to use the miracle material of graphene to solve some of the most challenging issues in their field.

Given graphene’s rather amazing properties, this should not come as much of a surprise. In addition to being incredibly thin, lightweight, and light-sensitive (it’s able to absorb light in both the UV and IR range) graphene also a very high surface area (2630 square meters per gram) which leads to remarkable conductivity. It also has the ability to bind or bioconjugate with various modifier molecules, and hence transform its behavior. 

brainscan_MRIAlready, it is being considered as a possible alternative to copper wires to break the energy efficiency barrier in computing, and even useful in quantum computing. But in the field of neurosurgery, where researchers are looking to develop materials that can bridge and even stimulate nerves. And in a story featured in latest issue of Neurosurgery, the authors suggest thatgraphene may be ideal as an electroactive scaffold when configured as a three-dimensional porous structure.

That might be a preferable solution when compared with other currently vogue ideas like using liquid metal alloys as bridges. Thanks to Samsung’s recent research into using graphene in their portable devices, it has also been shown to make an ideal E-field stimulator. And recent experiments on mice in Korea showed that a flexible, transparent, graphene skin could be used as a electrical field stimulator to treat cerebral hypoperfusion by stimulating blood flow through the brain.

Neuromorphic-chip-640x353And what look at the frontiers of neuroscience would be complete without mentioning neuromorphic engineering? Whereas neurohacking and neurosurgery are looking for ways to merge technology with the human brain to combat disease and improve its health, NE is looking to the human brain to create computational technology with improved functionality. The result thus far has been a wide range of neuromorphic chips and components, such as memristors and neuristors.

However, as a whole, the field has yet to define for itself a clear path forward. That may be about to change thanks to Jennifer Hasler and a team of researchers at Georgia Tech, who recently published a roadmap to the future of neuromorphic engineering with the end goal of creating the human-brain equivalent of processing. This consisted of Hasler sorting through the many different approaches for the ultimate embodiment of neurons in silico and come up with the technology that she thinks is the way forward.

neuromorphic-chip-fpaaHer answer is not digital simulation, but rather the lesser known technology of FPAAs (Field-Programmable Analog Arrays). FPAAs are similar to digital FPGAs (Field-Programmable Gate Arrays), but also include reconfigurable analog elements. They have been around on the sidelines for a few years, but they have been used primarily as so-called “analog glue logic” in system integration. In short, they would handle a variety of analog functions that don’t fit on a traditional integrated circuit.

Hasler outlines an approach where desktop neuromorphic systems will use System on a Chip (SoC) approaches to emulate billions of low-power neuron-like elements that compute using learning synapses. Each synapse has an adjustable strength associated with it and is modeled using just a single transistor. Her own design for an FPAA board houses hundreds of thousands of programmable parameters which enable systems-level computing on a scale that dwarfs other FPAA designs.

neuromorphic_revolutionAt the moment, she predicts that human brain-equivalent systems will require a reduction in power usage to the point where they are consuming just one-eights of what digital supercomputers that are currently used to simulate neuromorphic systems require. Her own design can account for a four-fold reduction in power usage, but the rest is going to have to come from somewhere else – possibly through the use of better materials (i.e. graphene or one of its derivatives).

Hasler also forecasts that using soon to be available 10nm processes, a desktop system with human-like processing power that consumes just 50 watts of electricity may eventually be a reality. These will likely take the form of chips with millions of neuron-like skeletons connected by billion of synapses firing to push each other over the edge, and who’s to say what they will be capable of accomplishing or what other breakthroughs they will make possible?

posthuman-evolutionIn the end, neuromorphic chips and technology are merely one half of the equation. In the grand scheme of things, the aim of all of this research is not only produce technology that can ensure better biology, but technology inspired by biology to create better machinery. The end result of this, according to some, is a world in which biology and technology increasingly resemble each other, to the point that they is barely a distinction to be made and they can be merged.

Charles Darwin would roll over in his grave!

Sources: nytimes.com, extremetech.com, (2), journal.frontiersin.org, pubs.acs.org

The Future of Medicine: Tiny Bladder and Flashlight Sensors

heart_patchesThere’s seems to be no shortage of medical breakthroughs these days! Whether it’s bionic limbs, 3-D printed prosthetic devices, bioprinting, new vaccines and medicines, nanoparticles, or embedded microsensors, researchers and medical scientists are bringing innovation and technological advancement together to create new possibilities. And in recent months, two breakthrough in particular have bbecome the focus of attention, offering the possibility of smarter surgery and health monitoring.

First up, there’s the tiny bladder sensor that is being developed by the Norwegian research group SINTEF. When it comes to patients suffering from paralysis, the fact that they cannot feel when their bladders are full, para and quadriplegics often suffer from pressure build-up that can cause damage to the bladder and kidneys. This sensor would offer a less invasive means of monitoring their condition, to see if surgery is required or if medication will suffice.

pressuresensorPresently, doctors insert a catheter into the patient’s urethra and fill their bladder with saline solution, a process which is not only uncomfortable but is claimed to provide an inaccurate picture of what’s going on. By contrast, this sensor can be injected directly into the patients directly through the skin, and could conceivably stay in place for months or even years, providing readings without any discomfort, and without requiring the bladder to be filled mechanically.

Patients would also able to move around normally, plus the risk of infection would reportedly be reduced. Currently readings are transmitted from the prototypes via a thin wire that extents from the senor out through the skin, although it is hoped that subsequent versions could transmit wirelessly – most likely to the patient’s smartphone. And given that SINTEF’s resume includes making sensors for the CERN particle collider, you can be confident these sensors will work!

senor_cern_600Next month, a clinical trial involving three spinal injury patients is scheduled to begin at Norway’s Sunnaas Hospital. Down the road, the group plans to conduct trials involving 20 to 30 test subjects. Although they’re currently about to be tested in the bladder, the sensors could conceivably be used to measure pressure almost anywhere in the body. Conceivably, sensors that monitor blood pressure and warn of aneurisms or stroke could be developed.

Equally impressive is the tiny, doughnut-shaped sensor being developed by Prof. F. Levent Degertekin and his research group at the George W. Woodruff School of Mechanical Engineering at Georgia Tech. Designed to assist doctors as they perform surgery on the heart or blood vessels, this device could provide some much needed (ahem) illumination. Currently, doctors and scientists rely on images provided by cross-sectional ultrasounds, which are limited in terms of the information they provide.

tiny_flashlightAs Degertekin explains:

If you’re a doctor, you want to see what is going on inside the arteries and inside the heart, but most of the devices being used for this today provide only cross-sectional images. If you have an artery that is totally blocked, for example, you need a system that tells you what’s in front of you. You need to see the front, back, and sidewalls altogether.

That’s where their new chip comes into play. Described as a “flashlight” for looking inside the human body, it’s basically a tiny doughnut-shaped sensor measuring 1.5 millimeters (less than a tenth of an inch) across, with the hole set up to take a wire that would guide it through cardiac catheterization procedures. In that tiny space, the researchers were able to cram 56 ultrasound transmitting elements and 48 receiving elements.

georgia-tech-flashlight-vessels-arteries-designboom03So that the mini monitor doesn’t boil patients’ blood by generating too much heat, it’s designed to shut its sensors down when they’re not in use. In a statement released from the university, Degertekin explained how the sensor will help doctors to better perform life-saving operations:

Our device will allow doctors to see the whole volume that is in front of them within a blood vessel. This will give cardiologists the equivalent of a flashlight so they can see blockages ahead of them in occluded arteries. It has the potential for reducing the amount of surgery that must be done to clear these vessels.

Next up are the usual animal studies and clinical trials, which Degertekin hopes will be conducted by licensing the technology to a medical diagnostic firm. The researchers are also going to see if they can make their device even smaller- small enough to fit on a 400-micron-diameter guide wire, which is roughly four times the diameter of a human hair. At that size, this sensor will be able to provide detailed, on-the-spot information about any part of the body, and go wherever doctors can guide it.

Such is the nature of the new age of medicine: smaller, smarter, and less invasive, providing better information to both save lives and improve quality of life. Now if we can just find a cure for the common cold, we’d be in business!

Sources: gizmag.com, news.cnet.com

The Future of Medicine: New Cancer Tests and Treatments

cancer_growingWhile a cure for cancer is still beyond medical science, improvements in how we diagnose and treat the disease are being made every day. These range from early detection, which makes all the difference in preventing the spread of the disease; to less-invasive treatments, which makes for a kinder, gentler recovery. By combining better medicine with cost-saving measures, accessibility is also a possibility.

When it comes to better diagnostics, the aim is to find ways to detect cancer without harmful and expensive scans or exploratory surgery. An alternative is a litmus test, like the one invented by Jack Andraka to detect pancreatic cancer. His method, which was unveiled at the 2012 Intel International Science and Engineering Fair (ISEF), won him the top prize due to the fact that it’s 90% accurate, 168 times faster than current tests and 1/26,000th the cost of regular tests.

cancer_peetestSince that time, Jack and his research group (Generation Z), have been joined by such institutions as MIT, which recently unveiled a pee stick test to detect cancer. In research published late last month in the Proceedings of the National Academy of Sciences, MIT Professor Sangeeta Bhatia reported that she and her team developed paper test strips using the same technology behind in-home pregnancy tests, ones which were able to detect colon tumors in mice.

The test strips work in conjunction with an injection of iron oxide nanoparticles, like those used as MRI contrast agents, that congregate at tumor sites in the body. Once there, enzymes known as matrix metalloproteinases (MMPs), which cancer cells use to invade healthy tissue, break up the nanoparticles, which then pass out through the patient’s urine. Antibodies on the test strip grab them, causing gold nanoparticles to create a red color indicating the presence of the tumor.

cancer_peetest2According to Bhatia, the technology is likely to make a big splash in developing countries where complicated and expensive medical tests are a rarity. Closer to home, the technology is also sure to be of significant use in outpatient clinics and other decentralized health settings. As Bhatia said in a press release:

For the developing world, we thought it would be exciting to adapt (the technology) to a paper test that could be performed on unprocessed samples in a rural setting, without the need for any specialized equipment. The simple readout could even be transmitted to a remote caregiver by a picture on a mobile phone.

To help Bhatia and her research team to bring her idea to fruition, MIT has given her and her team a grant from the university’s Deshpande Center for Technological Innovation. The purpose of the grant is to help the researchers develop a startup that could execute the necessary clinical trials and bring the technology to market. And now, Bhatia and her team are working on expanding the test to detect breast, prostate cancers, and all other types of cancer.

?????????????In a separate but related story, researchers are also working towards a diagnostic methods that do not rely on radiation. While traditional radiation scanners like PET and CT are good at finding cancer, they expose patients to radiation that can create a catch-22 situation where cancer can be induced later in life, especially for younger patients. By potentially inducing cancer in young people, it increases the likelihood that they will have to be exposed to more radiation down the line.

The good news is that scientists have managed to reduce radiation exposure over the past several years without sacrificing image quality. But thanks to ongoing work at the Children’s Hospital of Michigan, the Stanford School of Medicine, and Vanderbilt Children’s Hospital, there’s a potential alternative that involves combining MRI scans with a contrast agent, similar to the one Prof. Bhatia and her MIT group use in their peestick test.

cancer_braintumorAccording to a report published in the journal The Lancet Oncology, the researchers claimed that the new MRI approach found 158 tumors in twenty-two 8 to 33-year-olds, compared with 163 found using the traditional PET and CT scan combo. And since MRIs use radio waves instead of radiation, the scans themselves have no side effects. While the study is small, the positive findings are a step toward wider-spread testing to determine the effectiveness and safety of the new method.

The next step in testing this method will be to study the approach on more children and investigate how it might work in adults. The researchers say physicians are already launching a study of the technique in at least six major children’s hospitals throughout the country. And because the cost of each method could be roughly the same, if the MRI approach proves just as effective yet safer, radiation-free cancer scans are likely to be the way of the future.

cancer_georgiatechAnd last, but not least, there’s a revolutionary new treatment pioneered by researchers at Georgia Tech that relies on engineered artificial pathways to lure malignant cells to their death. This treatment is designed to address brain tumors – aka. Glioblastoma multiform cancer (GBM) – which are particularly insidious because they spread through the brain by sliding along blood vessels and nerve passageways (of which the brain has no shortage of!)

This capacity for expansion means that sometimes tumors developed in parts of the brain where surgery is extremely difficult – if not impossible – or that even if the bulk of a tumor can be removed, chances are good its tendrils would still exist throughout the brain. That is where the technique developed by scientists at Georgia Tech comes in, which involves creating artificial pathways along which cancer can travel to either more operable areas or even to a deadly drug located in a gel outside the body.

cancer_georgiatech1According to Ravi Bellamkonda, lead investigator and chair of the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University:

[T]he cancer cells normally latch onto … natural structures and ride them like a monorail to other parts of the brain. By providing an attractive alternative fiber, we can efficiently move the tumors along a different path to a destination that we choose.

The procedure was reported in a recent issue of the journal Nature Materials. It involved Bellamkonda and his team implanting nanofibers about half the size of a human hair in rat brains where GBMs were growing. The fibers were made from a polycaprolactone (PCL) polymer surrounded by a polyurethane carrier and mimicked the contours of the nerves and blood vessels cancer cells like to use as a biological route.

cancer_georgiatech2One end of a fiber was implanted into the tumor inside the brain and the other into a gel containing the drug cyclopamine (which kills cancer cells) outside the brain. After 18 days, enough tumor cells had migrated along the fiber into the gel to shrink the tumor size 93 percent. Not only does Bellamkonda think his technique could be used to relocate and/or destroy cancers, he says he believes it could be used to help people live with certain inoperable cancers as a chronic condition.

In a recent statement, Bellakomba had this to say about the new method and the benefits its offers patients:

If we can provide cancer an escape valve of these fibers, that may provide a way of maintaining slow-growing tumors such that, while they may be inoperable, people could live with the cancers because they are not growing. Perhaps with ideas like this, we may be able to live with cancer just as we live with diabetes or high blood pressure.

Many of today’s methods for treating cancer focus on using drugs to kill tumors. The Georgia Tech team’s approach was engineering-driven and allows cancer to be treated with a device rather than with chemicals, potentially saving the patient many debilitating side effects. Part of the innovation in the technique is that it’s actually easier for tumors to move along the nanofibers than it is for them to take their normal routes, which require significant enzyme secretion as they invade healthy tissue.

cancer_georgiatech3Anjana Jain, the primary author of the study, was also principally responsible for the design of the nanofiber technique. After doing her graduate work on biomaterials used for spinal cord regeneration, she found herself working in Bellamkonda’s lab as a postdoctoral fellow and came up with the idea of routing materials using engineered materials. In a recent statement, she said the following of her idea:

Our idea was to give the tumor cells a path of least resistance, one that resembles the natural structures in the brain, but is attractive because it does not require the cancer cells to expend any more energy.

Extensive testing, which could take up to 10 years, still needs to be conducted before this technology can be approved for use in human patients. In the meantime, Bellamkonda and his team will be working towards using this technology to lure other cancers that like to travel along nerves and blood vessels. With all the advances being made in diagnostics, treatments, and the likelihood of a cure being found in the near future, the 21st century is likely to be the era where cancer becomes history.

Sources: news.cnet.com, (2), (3)